当前位置: 首页 > 医疗版 > 疾病专题 > 胃肠外科 > 小肠、结肠疾病 > 肠癌 > 大肠癌
编号:13283583
沉默Ambra1基因增强大肠癌细胞对5—FU的化疗敏感性(1)
http://www.100md.com 2018年8月15日 《中国医学创新》 2018年第23期
     【摘要】 目的:觀察5-FU对沉默Ambra1基因的大肠癌细胞的化疗敏感性影响。方法:将靶向Ambra1基因的siRNA转染至大肠癌细胞HCT15和HCT116,用Real-time PCR和Western blotting方法检测Ambra1 mRNA和蛋白的表达;采用MTS方法检测HCT15和HCT116细胞的活力。结果:HCT15、HCT116细胞转染siRNA-Ambra1-1、siRNA-Ambra1-2后的Ambra1 mRNA表达水平均分别低于siRNA-Ambra1-HCT15-NC、siRNA-Ambra1-HCT116-NC细胞(P<0.05);HCT15、HCT116细胞转染后的蛋白表达均低于阴性对照;4 μg/mL时,HCT15和HCT116细胞转染siRNA-Ambra1-1、siRNA-Ambra1-2后的细胞克隆形成数均少于0 μg/mL(P<0.05),而且HCT15、HCT116细胞转染siRNA-Ambra1-1、siRNA-Ambra1-2后的细胞克隆形成数均分别少于siRNA-Ambra1-HCT15-NC、siRNA-Ambra1-HCT116-NC(P<0.05);HCT15、HCT116细胞转染siRNA-Ambra1-1、siRNA-Ambra1-2后的细胞生存率均分别低于siRNA-Ambra1-HCT15-NC、siRNA-Ambra1-HCT116-NC(P<0.05);且随着药物浓度增加,已转染了siRNA-Ambra1的细胞生存率均低于阴性对照组。结论:沉默Ambral基因可提高大肠癌细胞对5-FU的化疗敏感性。
, 百拇医药
    【关键词】 大肠癌; siRNA; Ambra1; 化疗敏感性; 5-FU

    siRNA-Ambra1 Enhances Chemosensitivity of Human Colon Cancer Cells for 5-FU/WANG Liantao,CHENG Haichun,WEN Huasheng,et al.//Medical Innovation of China,2018,15(23):0-043

    【Abstract】 Objective:To observe the effect of 5-FU on chemosensitivity of colorectal cancer cells silencing Ambra1 gene.Method:siRNA targeting Ambra1 gene was transfected into colorectal cancer cells HCT15 and HCT116.The expressions of Ambra1 mRNA and protein were detected by Real-time PCR and Western blotting.The viability of HCT15 and HCT116 cells was detected by MTS.Result:The expression levels of Ambra1 mRNA in HCT15 and HCT116 cells transfected with siRNA-Ambra1-1 and siRNA-Ambra1-2 were lower than those of siRNA-Ambra1-HCT15-NC and siRNA-Ambra1-HCT116-NC cells respectively(P<0.05).The protein expression of HCT15 and HCT116 cells after transfection were lower than those of negative control.When 4 μg/mL,the cell clone formation number of HCT15 and HCT116 cells transfected with siRNA-Ambra1-1 and siRNA-Ambra1-2 were less than 0 μg/mL(P<0.05),and the cell clone formation number of HCT15 and HCT116 cells transfected with siRNA-Ambra1-1 and siRNA-Ambra1-2 were less than those of siRNA-Ambra1-HCT15-NC and siRNA-Ambra1-HCT116-NC cells respectively(P<0.05).The cell survival rates of HCT15 and HCT116 cells transfected with siRNA-Ambra1-1 and siRNA-Ambra1-2 were lower than those of iRNA-Ambra1-HCT15-NC and siRNA-Ambra1-HCT116-NC cells respectively(P<0.05),with the increase of drug concentration,the survival rate of the transfected siRNA-Ambra1 cells was lower than that of the negative control group.

    Conclusion:siRNA-Ambralcan enhance chemotherapy sensitivity of colon cancer cells to 5-FU.

    【Key words】 Colon cancer; Small interfering RNA; Ambra1; Chemotherapy sensitivity; 5-FU, http://www.100md.com(王连涛 成海春 温华生)
1 2 3 4 5下一页


    参见:首页 > 医疗版 > 疾病专题 > 胃肠外科 > 小肠、结肠疾病 > 肠癌 > 大肠癌